“Influenza Vaccine 2,000,000X” (2019, watercolor and ink on paper) shows a modern recombinant vaccine created by biotechnology in the process of binding to the surface of a B-cell. This will ultimately lead to production of antiviral antibodies.

Get the Full Experience
Read the rest of this article, and view all articles in full from just £10 for 3 months.

Subscribe Today
No comments yet.

You must be a subscriber and logged in to leave a comment. Users of a Site License are unable to comment.

Log in Now | Subscribe Today